Biotech startups that raised Series A in Zhejiang, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Prime Lifescience | Hangzhou | Series A | $14.7M | 2026-06-30 |
| Dishi Medical | Hangzhou | Series A | $13.7M | 2026-01-19 |
| Zhongke Guosheng | Hangzhou | Series A | $27.6M | 2025-03-05 |
| AnDiConBio | Jiaxing | Series A | $27.6M | 2024-04-29 |
| Rebbeca Med | Hangzhou | Series A | $9.2M | 2024-02-01 |
5 rows of the CSV in 5 of its 18 columns.
- The 56 biotech startups in Zhejiang, China whose last round is Series A have raised $545.7M in total.
- 11 of them closed their most recent round in the last 12 months, $99.1M combined.
- The largest of those rounds is Mesai Biotech's $21.8M Series A, dated April 2026.
- The most recent is Enginprime Medical's $12.0M Series A on 17 August 2026.
- Qiji Investment is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 46 companies (82%).
- 39% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (51% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
4 of 56| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Hangzhou | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Hangzhou | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
| AnDiConBio | AnDiConBio develops respiratory anti-infection drugs for pain and respiratory conditions. | Biotech | Jiaxing | Series A | $27.6M | 2024-04-29 | $27.6M | Cowin Capital, Wenzhou Capital, Huajin Avenue Investment | 11 to 50 | 2018 |
| Aoshi Environmental | Aoshi Environmental produces high-performance reverse osmosis and nanofiltration membrane separation products. | Biotech | Huzhou | Series A | $13.8M | 2024-04-03 | Glory Ventures, ZSVC, Changxing Financial Holdings | 2020 |
Table 1. Biotech startups that raised Series A in Zhejiang, China: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 56.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Hangzhou | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| 2 | Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Hangzhou | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
Table 2. Biotech startups that raised Series A in Zhejiang, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiji Investment | Venture capital firm | Suzhou, China | 2 | 4% | 1 | Prime Lifescience |
| 2 | Pan-Lin Capital | Venture capital firm | Shanghai, China | 2 | 4% | ||
| 3 | Taiyu Investment | Venture capital firm | Beijing, China | 2 | 4% | ||
| 4 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Prime Lifescience |
| 5 | Ennovation Ventures | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Prime Lifescience |
| 6 | Junan Holdings | Ningbo, China | 1 | 2% | 1 | Astathera | |
| 7 | Linear Capital | Venture capital firm | Shanghai, China | 1 | 2% | 1 | Dishi Medical |
| 8 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 1 | 2% | 1 | Dishi Medical |
| 9 | Infinity Equity | Private equity firm | Wan Chai, Hong Kong | 1 | 2% | 1 | Dishi Medical |
| 10 | Hillhouse Investment | Angel group | Singapore | 1 | 2% | 1 | Dishi Medical |
| 11 | Meridian Capital Asia | Private equity firm | Singapore | 1 | 2% | ||
| 12 | Legend Capital | Venture capital firm | Beijing, China | 1 | 2% | ||
| 13 | Matrix Partners China | Venture capital firm | Beijing, China | 1 | 2% | ||
| 14 | 5Y Capital | Venture capital firm | Xuhui, China | 1 | 2% | ||
| 15 | Jianxin Capital | Venture capital firm | Shanghai, China | 1 | 2% |
Table 3. Biotech startups that raised Series A in Zhejiang, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 46 | 82% | $466.3M |
| Software | 3 | 5% | $44.5M |
| Artificial intelligence | 1 | 2% |
Table 4. Biotech startups that raised Series A in Zhejiang, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 56 | 100% | $13.7M |
Table 5. Biotech startups that raised Series A in Zhejiang, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Hangzhou | 37 | 66% |
| Ningbo | 4 | 7% |
| Jiaxing | 3 | 5% |
| Shaoxing | 2 | 4% |
| Yuhang | 2 | 4% |
| Changzhou | 2 | 4% |
| Huzhou | 2 | 4% |
| Wenzhou | 1 | 2% |
| Fenghua | 1 | 2% |
| Linhai | 1 | 2% |
| Quzhou | 1 | 2% |
Table 6. Biotech startups that raised Series A in Zhejiang, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| August 2026 | 1 | 9% | $12.0M |
| July 2026 | 1 | 9% | $14.0M |
| June 2026 | 1 | 9% | $14.7M |
| May 2026 | 1 | 9% | |
| April 2026 | 2 | 18% | $23.2M |
| February 2026 | 1 | 9% | |
| January 2026 | 2 | 18% | $20.9M |
| December 2025 | 1 | 9% | $14.1M |
| November 2025 | 1 | 9% |
Table 7. Biotech startups that raised Series A in Zhejiang, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 9 | 16% | $84.9M |
| 2025 | 9 | 16% | $41.7M |
| 2024 | 11 | 20% | $127.9M |
| 2023 | 4 | 7% | $44.1M |
| 2022 | 5 | 9% | $22.3M |
| 2021 | 2 | 4% | $68.8M |
Table 8. Biotech startups that raised Series A in Zhejiang, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 2% |
| 2020 to 2022 | 20 | 37% |
| 2015 to 2019 | 23 | 43% |
| 2010 to 2014 | 5 | 9% |
| Before 2010 | 5 | 9% |
Table 9. Biotech startups that raised Series A in Zhejiang, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 4 | 9% |
| 11 to 50 | 22 | 51% |
| 51 to 100 | 11 | 26% |
| 101 to 250 | 2 | 5% |
| 251 to 500 | 4 | 9% |
Table 10. Biotech startups that raised Series A in Zhejiang, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Zhejiang, China. On 16 November 2026 that is 56 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 4 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 56 rows: 24 have no round amount, 0 no city and 22 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Zhejiang, China whose last round is Series A are on the list?
- 56, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 56 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.